Literature DB >> 25872513

Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales.

Lorna Harper1, Frederik Barkhof2, Nick C Fox1, Jonathan M Schott1.   

Abstract

Visual rating scales, developed to assess atrophy in patients with cognitive impairment, offer a cost-effective diagnostic tool that is ideally suited for implementation in clinical practice. By focusing attention on brain regions susceptible to change in dementia and enforcing structured reporting of these findings, visual rating can improve the sensitivity, reliability and diagnostic value of radiological image interpretation. Brain imaging is recommended in all current diagnostic guidelines relating to dementia, and recent guidelines have also recommended the application of medial temporal lobe atrophy rating. Despite these recommendations, and the ease with which rating scales can be applied, there is still relatively low uptake in routine clinical assessments. Careful consideration of atrophy rating scales is needed to verify their diagnostic potential and encourage uptake among clinicians. Determining the added value of combining scores from visual rating in different brain regions may also increase the diagnostic value of these tools. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  ALZHEIMER'S DISEASE; DEMENTIA; MRI; NEURORADIOLOGY; SCALES

Mesh:

Year:  2015        PMID: 25872513     DOI: 10.1136/jnnp-2014-310090

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  53 in total

1.  The impact of MRI combined with visual rating scales on the clinical diagnosis of dementia: a prospective study.

Authors:  Martijn V Verhagen; Gerard L Guit; Gerrit Jan Hafkamp; Kees Kalisvaart
Journal:  Eur Radiol       Date:  2015-08-29       Impact factor: 5.315

2.  Reversible amygdala enlargement: a longitudinal observation of a patient with elderly onset temporal lobe epilepsy.

Authors:  Takashi Matsudaira; Yoshio Omote; Tatsuhiro Terada; Akihiko Kondo; Tomokazu Obi; Yasuomi Ouchi; Yushi Inoue
Journal:  J Neurol       Date:  2017-10-24       Impact factor: 4.849

Review 3.  Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia.

Authors:  Nasim Sheikh-Bahaei; Seyed Ahmad Sajjadi; Aimee L Pierce
Journal:  Curr Treat Options Neurol       Date:  2017-11-14       Impact factor: 3.598

4.  Nuclear medical imaging as part of dementia diagnostics in psychiatric day-care clinics and inpatient care settings.

Authors:  Jonathan Vogelgsang; Bernhard Kis; Katrin Radenbach; Claus Wolff-Menzler; Kiriaki Mavridou; Charles Timäus; Stephan Gyßer; Jens Wiltfang; Philipp Hessmann
Journal:  Aging Clin Exp Res       Date:  2019-07-08       Impact factor: 3.636

5.  Characteristic asymmetric limbic and anterior temporal atrophy in demented patients with pathologically confirmed argyrophilic grain disease.

Authors:  Keita Sakurai; Aya M Tokumaru; Toshimasa Ikeda; Satoru Morimoto; Shohei Inui; Kaoru Sumida; Hiroshi Oba; Motoo Nakagawa; Noriyuki Matsukawa; Yoshio Hashizume
Journal:  Neuroradiology       Date:  2019-06-29       Impact factor: 2.804

6.  Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment.

Authors:  Min Young Chun; Geon Ha Kim; Hee Kyung Park; Dong Won Yang; SangYun Kim; Seong Hye Choi; Jee Hyang Jeong
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

7.  Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations.

Authors:  Laura L Gramegna; Stefania Evangelisti; Lidia Di Vito; Chiara La Morgia; Alessandra Maresca; Leonardo Caporali; Giulia Amore; Lia Talozzi; Claudio Bianchini; Claudia Testa; David N Manners; Irene Cortesi; Maria L Valentino; Rocco Liguori; Valerio Carelli; Caterina Tonon; Raffaele Lodi
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

8.  Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study.

Authors:  Hugh G Pemberton; Olivia Goodkin; Ferran Prados; Ravi K Das; Sjoerd B Vos; James Moggridge; William Coath; Elizabeth Gordon; Ryan Barrett; Anne Schmitt; Hefina Whiteley-Jones; Christian Burd; Mike P Wattjes; Sven Haller; Meike W Vernooij; Lorna Harper; Nick C Fox; Ross W Paterson; Jonathan M Schott; Sotirios Bisdas; Mark White; Sebastien Ourselin; John S Thornton; Tarek A Yousry; M Jorge Cardoso; Frederik Barkhof
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

9.  Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants.

Authors:  David J Seiffge; Duncan Wilson; Gareth Ambler; Gargi Banerjee; Isabel Charlotte Hostettler; Henry Houlden; Clare Shakeshaft; Hannah Cohen; Tarek A Yousry; Rustam Al-Shahi Salman; Gregory Lip; Martin M Brown; Keith Muir; H R Jäger; David J Werring
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-19       Impact factor: 10.154

10.  MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.

Authors:  Lorna Harper; Giorgio G Fumagalli; Frederik Barkhof; Philip Scheltens; John T O'Brien; Femke Bouwman; Emma J Burton; Jonathan D Rohrer; Nick C Fox; Gerard R Ridgway; Jonathan M Schott
Journal:  Brain       Date:  2016-03-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.